
This is the largest consolidated outpatient imaging in the US. There are about 6500 clinics that provides imaging services on an outpatient basis and RadNet has been consolidating the space. They have a few hundred of these, so there a lot more growth is possible. The private-clinic model is increasingly popular because it provides patients with lower copays. (Analyst’s price target is $16.33)
RadNet is a OTC stock, trading under the symbol RDNT-O on the undefined (undefined). It is usually referred to as or RDNT-O
In the last year, no analyst issued a Buy, Sell, or Hold rating on RDNT-O on Stockchase. Read the latest expert commentary for RadNet.
RadNet was recommended as a Top Pick by Genevieve Roch-Decter on 2018-06-19. Read the latest stock experts ratings for RadNet.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for RadNet.
RadNet is covered by Stockchase experts and is worth watching.
Is up 7,631% over 20 years. There's a lot of demand for MRI scans outside hospitals, less expensively. This pulled back 45% since last year's high and the stock remains expensive, but this will work if you are long term.